Diagnostic accuracy of NS1 ELISA and lateral flow rapid tests for dengue sensitivity, specificity and relationship to viraemia and antibody responses

PLoS Neglected Tropical Diseases

Volumn 3, Issue 1, 2009, Pages

  Hang, Vu Ty ^a   Nguyet, Nguyen Minh ^a,b   Trung, Dinh The ^a,b   Tricou, Vianney ^a   Yoksan, Sutee ^c   Dung, Nguyen Minh ^b   Ngoc, Tran Van ^b   Hien, Tran Tinh ^b   Farrar, Jeremy ^a,d   Wills, Bridget ^a,d   Simmons, Cameron P ^a,d  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c MAHIDOL UNIVERSITY   (Thailand)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NONSTRUCTURAL PROTEIN 1; VIRUS ANTIBODY; VIRUS PROTEIN;

ADULT; ALGORITHM; ANALYTIC METHOD; ANTIBODY RESPONSE; ARTICLE; CHILD; CONTROLLED STUDY; DENGUE; DIAGNOSTIC ACCURACY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC ENCEPHALITIS; FEMALE; HUMAN; HUMORAL IMMUNITY; INTERMETHOD COMPARISON; LATERAL FLOW RAPID TEST; LEPTOSPIROSIS; MAJOR CLINICAL STUDY; MALARIA; MALE; PROTEIN ANALYSIS; SENSITIVITY AND SPECIFICITY; TYPHOID FEVER; VIET NAM; VIREMIA; ADOLESCENT; ANALYTICAL EQUIPMENT; ANTIBODY PRODUCTION; BLOOD; COMPARATIVE STUDY; DENGUE VIRUS; EARLY DIAGNOSIS; EVALUATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; PRESCHOOL CHILD; VIRUS LOAD;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CHILD; CHILD, PRESCHOOL; DENGUE; DENGUE VIRUS; EARLY DIAGNOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; VIETNAM; VIRAL LOAD; VIRAL NONSTRUCTURAL PROTEINS; VIREMIA;

EID: 65549138517     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000360     Document Type: Article

References (20)

1. Guzman MG, Kouri G (2002) Dengue: an update. Lancet Infect Dis 2: 33-42.
2. Monath TP (1994) Dengue: the risk to developed and developing countries. Proc Natl Acad Sci U S A 91: 2395-2400.
3. Mackenzie JM, Jones MK, Young PR (1996) Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology 220: 232-240.
4. Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, et al. (2002) High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis 186: 1165-1168.
5. Avirutnan P, Punyadee N, Noisakran S, Komoltri C, Thiemmeca S, et al. (2006) Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis 193: 1078-1088.
6. Avirutnan P, Zhang L, Punyadee N, Manuyakorn A, Puttikhunt C, et al. (2007) Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. PLoS Pathog 3: e183. doi:10.1371/journal.ppat.0030183.
7. Dussart P, Petit L, Labeau B, Bremand L, Leduc A, et al. (2008) Evaluation of Two New Commercial Tests for the Diagnosis of Acute Dengue Virus Infection Using NS1 Antigen Detection in Human Serum. PLoS Negl Trop Dis 2: e280. doi:10.1371/journal.pntd.0000280.
8. Bessoff K, Delorey M, Sun W, Hunsperger E (2008) Comparison of 2 Commercially Available Dengue NS1 Capture Enzyme-Linked Immunosorbant Assays for Diagnosis of Acute DENV Infection with a Single Clinical Sample. Clin Vaccine Immunol.
9. Kumarasamy V, Chua SK, Hassan Z, Wahab AH, Chem YK, et al. (2007) Evaluating the sensitivity of a commercial dengue NS1 antigen-capture ELISA for early diagnosis of acute dengue virus infection. Singapore Med J 48: 669-673.
10. Kumarasamy V, Wahab AH, Chua SK, Hassan Z, Chem YK, et al. (2007) Evaluation of a commercial dengue NS1 antigen-capture ELISA for laboratory diagnosis of acute dengue virus infection. J Virol Methods 140: 75-79.
11. Dussart P, Labeau B, Lagathu G, Louis P, Nunes MR, et al. (2006) Evaluation of an enzyme immunoassay for detection of dengue virus NS1 antigen in human serum. Clin Vaccine Immunol 13: 1185-1189.
12. Blacksell SD, Mammen MP Jr, Thongpaseuth S, Gibbons RV, Jarman RG, et al. (2008) Evaluation of the Panbio dengue virus nonstructural 1 antigen detection and immunoglobulin M antibody enzyme-linked immunosorbent assays for the diagnosis of acute dengue infections in Laos. Diagn Microbiol Infect Dis 60: 43-49.
13. Chuansumrit A, Chaiyaratana W, Pongthanapisith V, Tangnararatchakit K, Lertwongrath S, et al. (2008) The use of dengue nonstructural protein 1 antigen for the early diagnosis during the febrile stage in patients with dengue infection. Pediatr Infect Dis J 27: 43-48.
14. Lapphra K, Sangcharaswichai A, Chokephaibulkit K, Tiengrim S, Piriyakarnsakul W, et al. (2008) Evaluation of an NS1 antigen detection for diagnosis of acute dengue infection in patients with acute febrile illness. Diagn Microbiol Infect Dis 60: 387-391.
15. Cardosa MJ, Wang SM, Sum MS, Tio PH (2002) Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses. BMC Microbiol 2: 9.
16. Innis BL, Nisalak A, Nimmannitya S, Kusalerdchariya S, Chongswasdi V, et al. (1989) An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg 40: 418-427.
17. Simmons CP, Popper S, Dolocek C, Chau TN, Griffiths M, et al. (2007) Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. J Infect Dis 195: 1097-1107.
18. Keller TH, Chen YL, Knox JE, Lim SP, Ma NL, et al. (2006) Finding new medicines for flaviviral targets. Novartis Found Symp 277: 102-114; discussion 114-109, 251-103.
19. Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, et al. (2002) Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 185: 1213-1221.
20. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, et al. (2000) Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181: 2-9.